Australis Capital Inc. announced that following shareholder support at the November 17, 2020 annual and special meeting of shareholders, the new AUSA board has rapidly commenced executing on the initiatives. Out of the gate, a number of board committees were formed, focused on discovery, execution and governance. The transition process also includes a rapid but thorough strategic review of current assets, relationships, internal operations and contractual arrangements. Furthermore, the board anticipates making new officer appointments, as well as implementing other organizational changes that will create a more agile, efficient and execution focused company, while reducing expenses. The company announced that governance is a key focus of the new team. In accordance with best practice standards and regulations, a number of board committees were formed, as follows: Audit Committee: Hanoz Kapadia (Chair), Avi Geller and John Esteireiro; Compensation and Nominating Committee: Jason Dyck (Chair), John Esteireiro and Avi Geller; Governance Committee: Duke Fu (Chair), Hanoz Kapadia and Jason Dyck; and Special Committee for the Green Therapeutics litigation: Hanoz Kapadia (Chair), Avi Geller and Jason Dyck.